Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
X. Nguyenla, E. Wehri, E. Van Dis, S. Biering, L. H. Yamashiro, J. Stroumza, C. Dugast-Darzacq, T. Graham, S. Stanley, J. Schaletzky
This study identifies 20 approved drugs that synergize with remdesivir to inhibit SARS-CoV-2 replication in human lung cells, with HCV NS5A inhibitors showing the strongest effects.
bioRxiv · Sep 18, 2020Microbiology